Results 261 to 270 of about 70,680 (286)
Some of the next articles are maybe not open access.
Biopharmaceutical benchmarks 2010
Nature Biotechnology, 2010Over the past four years, several new types of experimental biologic treatment have received commercial registration, but the emergence of biosimilars represents the biggest shift in the biologic approval landscape.
openaire +2 more sources
European Biopharmaceutical Culture
Nature Biotechnology, 1990Article synthese abordant le cote economique de l'utilisation du genie genetique pour la production de molecules recombinantes, par les industries biopharmaceutiques ...
openaire +2 more sources
Biopharmaceutical benchmarks 2006
Nature Biotechnology, 2006The rate of biopharmaceutical approvals has leveled off, but some milestones bode well for the future.
openaire +2 more sources